Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT02802982

Mathematical Modeling to Predict the Duration of Thrombocytopenia in Neonates

Sponsor: Boston Children's Hospital

View on ClinicalTrials.gov

Summary

Parents of infants who have been thrombocytopenic for 3-4 days will be approached for consent to enter the study. For the purposes of the study, thrombocytopenia will be defined as a platelet count \<60,000/uL or a platelet count \<100,000/uL that prompted a platelet transfusion. Following enrollment, the platelet count will be followed in each infant. Participants will enter the study if on day 5 or later after the onset of thrombocytopenia (defined as above) infants either have a platelet count \<60,000/uL or a platelet count \<100,000/uL for which a platelet transfusion is ordered.

Key Details

Gender

All

Age Range

5 Days - 3 Months

Study Type

OBSERVATIONAL

Enrollment

28

Start Date

2013-04

Completion Date

2024-12

Last Updated

2024-05-16

Healthy Volunteers

No

Locations (3)

The University of Iowa

Iowa City, Iowa, United States

Boston Children's Hospital

Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States